Lyme disease, science, and society: Camp Other
Showing posts with label bacteria. Show all posts
Showing posts with label bacteria. Show all posts

Sunday, October 28, 2012

0 Symbiotic Spirochetes In Animal Models

Recently, I noticed this intriguing item in the news that is of interest to many medical professionals around the world who are struggling to care for patients' difficult to eradicate C. difficile infections: A recent murine study[1] provided evidence that a simple mixture of six phylogenetically diverse intestinal bacteria - including novel species - can re-establish a health-associated microbiota and clear C. difficile infection from mice.

With this outcome, it's possible that medical professionals will no longer apply the treatment of last resort - fecal transplants - to save human patients' lives. Instead, all patients with raging C. difficile infections will have to do is swallow a pill or consume food that contains the strains of bacteria needed to reverse dysbiosis and rebalance the microbiota in their stomachs so that C. difficile is no longer a threat.

Over time, researchers are uncovering the complicated dynamic between different microorganisms which live inside the human gut. Also, they are refining their understanding of the dynamic between different microorganisms inside animals with increasing speed as more invasive studies can be completed in animals than can be easily completed in humans. Among these studies are those on the relationship between spirochetes and other microorganisms found in ruminants such as cattle and sheep, termites, and molluscs.

Symbiotic Spirochetes In Termites
 

Microscopic image of Mixotricha paradoxa
covered with thousands of Treponema spirochetes
One interesting and complex symbiotic relationship involving spirochetes is found within termites' guts. Spirochetes are one of the most abundant bacteria present in the gut fluid of termites, and the symbiotic relationship between various microbes in termites of all kinds actually predates the evolution of termites from their wood-feeding roach ancestors over 120 million years ago [2].

Most termites have spirochetes which are free-living in the gut fluid, but they have also been found as ectosymbionts attached to protists inside termite guts. Mixotricha paradoxa is protozoa found inside the gut of the Australian termite species, Mastotermes darwiniensis. It was originally thought the long tiny hair-like structures covering the length of its body were short cilia - outgrowths from the protozoa itself. However, upon closer examination years later, scientists Cleveland and Grimstone[3] discovered these were not cilia but a dense carpet of Treponema spirochetes - spirochetes which help propel Mixotricha paradoxa forward while it uses its own anterior flagella to steer in the right direction. How it coordinates this movement is unknown - it is surmised that they automatically synchronize due to their proximity.

These spirochetes not only help Mixotricha paradoxa move forward, though. One thing Mixotricha paradoxa does to help its host, the termite, do is help break down cellulose into sugars and then hydrogen, acetate, and carbon dioxide from the wood it eats. From there, what the Treponema spirochetes are predicted to do is oxidize the acetate which was produced and use it to support 100% of the termite's respiration requirements.[4]

What makes this symbiosis even more complex is that it doesn't stop there. No, not only does Mixotricha paradoxa have a Treponema spirochete helping it survive - but it also has three more bacterial species onboard: A lot of rod-shaped bacteria related to Bacteroides live on its surface, and is suspected to help breakdown cellulose as it sits alongside the Treponema spirochetes; a spherical form of bacteria lives inside Mixotricha which is hypothesized to act as mitochondria for the protozoa (as Mixotricha does not have its own mitochondria); a large spirochete attributed to the genus Canaleparolina.[5]

Not much is known about these three bacterial species' lives in Mixotricha paradoxa, and more research is needed. The most recent research on Mixotricha paradoxa adds to this complex symbiotic dynamic, as it has been discovered that not all glycolytic activities in Mixotricha paradoxa are produced by its microorganisms - cellulases have been detected in the salivary glands of Mastotermes darwiniensis - the termite itself.[6]

Symbiotic Spirochetes In Ruminants

The bovine or cow stomach has a wide variety of organisms inside it - such as fungi, bacteria, archaea, protista, and viruses. All these organisms help break down food, especially plant matter and in particular, cellulose. And like the Mixotricha paradoxa inside the Australian termite, Mastotermes darwiniensis, the organisms are all dependent on each other to some degree and use the byproducts of one another for their own benefit.

Cows - unlike people - have four stomach compartments to digest their food: the rumen, the reticulum, the omasum, and the abomasum. The rumen is the largest compartment, and it contains a huge number of different microbes. The reticulum is responsible for creating cud and trapping indigestible substances like rocks or nails - and unfortunately, can be subject to more injury than the other compartments. The omasum sends large substances to the rumen and reticulum while allowing smaller substances to pass on to the abomasum. And the abomasum is very similar to a human stomach, as it produces stomach acids and enzymes to break down proteins before sending the result to the small intestine.

While the most common bacteria in the bovine stomach are gram-positive cocci and rods, a smaller percentage of their population are spirochetes which play a role in ruminant digestion. Organisms such as Treponema bryantii, a saccharolytic spirochete, enhances the breakdown of cellulose while cellulolytic bacteria of different species break down plant cell walls into soluble sugars.

Two interesting passages from the publication, Interspecies bacterial interactions in biofilms, by James, Beaudette, and Costerton[7], highlight the relationship between Treponema bryantii and other microbes studied in vitro from bovine rumen:
"Observations of biofilms on cellulose particles from the rumen revealed cellulolytic as well as noncellulolytic bacteria enmeshed in the exopolysaccharide matrix of the biofilm. Addition of a noncellulolytic species, Treponema bryantii, to cultures of a cellulolytic species, Fibrobacter succinogenes or Ruminococcus albus, resulted in an enhanced rate of cellulose degradation. Presumably, T. bryantii utilized the hydrolytic products (eg, glucose or cellobiose) from the cellulolytic bacteria which may repress and/or inhibit the cellulolytic enzymes."

"...Microscopy of biofilms formed during protocooperative cellulose digestion by R. flavefaciens and T. bryantii revealed that cellulolytic R. flavefaciens cells were attached directly to cellulose particles, while the spirochete, T. bryantii, was located in the upper biofilm layers. This spatial arrangement and the mobility of spirochetes in viscous environments suggest that this organism may move through the biofilm, scavenging the products of the cellulolytic bacteria."
The first study of Treponema bryantii in 1980, Treponema bryantii sp. nov., a rumen spirochete that interacts with cellulolytic bacteria[8], offers more specifics in its abstract as to its biological requirements:
"...When cocultured in these media the spirochete used, as fermentable substrates, soluble sugars released from cellulose by the cellulolytic bacterium. In cellulose-containing agar medium the spirochete enhanced cellulose breakdown by the Bacteroides succinogenes strain. Electron microscopy showed that the helical spirochete cells possessed an outer sheath, a protoplasmic cylinder, and two periplasmic fibrils. Under a CO2 atmosphere, in a reduced medium containing inorganic salts, rumen fluid, glucose, and NaHCO3, the spirochete grew to a final density of 1.9 X 10(9) cells/ml. Succinate, acetate, and formate were products of the fermentation of glucose by growing cells. CO2 (HCO3-), branched short-chain fatty acids, folic acid, biotin, niacinamide, thiamine, pyridoxal, and a carbohydrate were required for growth of the spirochete."
Spirochete Symbiosis In Molluscs

While so far there is no evidence molluscs harbor spirochetes which have symbiotic relationships with its host or other microorganisms, spirochetes which coexist peacefully within their host are worth noting.

Spirochetes from the genus Cristispira have been found inside more than 50 species of 22 families of marine bivalves and 3 freshwater bivalves. It has been shown to be a commensal organism living within molluscs and has not been shown to provide any benefit or disadvantage to molluscs such as Prince Edward Island oysters.

This past May, an interesting paper was published, Spirochetes in gastropods from Lake Baikal and North American freshwaters: new multi-family, multi-habitat host records[9].

The abstract states:
"We describe the first records of spirochetes in the gut of fourteen species of continental gastropods from a range of habitats and representing six families (Amnicolidae, Baicaliidae, Bithyniidae, Pyrgulidae, Lithoglyphidae and Benedictiidae). The bacteria were mainly found in the crystalline style sac, as has been reported in marine bivalves. The surveyed habitats include water bodies in North America and Eurasia, including deep water hydrothermal vent and gas hydrate zones in Lake Baikal. Spirochetes were present both in mature and young snails, but were not detected in embryos before hatching, indicating lateral transfer. The surveyed gastropods range in trophic strategy, including phyto-, detrito- and bacteriophagous grazers and filter feeders. Our results indicate that spirochetes are commensal in the surveyed gastropods with potential limited benefit and no detriment to the host animal. We suggest that the specialized internal habitat of the crystalline style sac in molluscs is likely to reveal unrecognized spirochete diversity that will shed new light on gastropod trophic ecology and spirochete diversity."
More research is needed to determine which limited benefits different spirochetes may provide for their hosts.

Looking at the symbiotic and commensal relationships between animals and spirochetes - or between spirochetes and other microbes - one has to wonder what kind of relationships different spirochetes have with us and microbes within us. Humans already play host to spirochetes which are considered commensal Treponema and unfortunate hosts to spirochetes which are pathogenic such as those which cause syphilis and Lyme disease (Borreliosis). But is there more to this story than is often told? Do these bacteria have deeper relationships?

References:

1) Trevor D. Lawley, Simon Clare, Alan W. Walker, Mark D. Stares, Thomas R. Connor, Claire Raisen, David Goulding, Roland Rad, Fernanda Schreiber, Cordelia Brandt, Laura J. Deakin, Derek J. Pickard, Sylvia H. Duncan, Harry J. Flint, Taane G. Clark, Julian Parkhill, Gordon Dougan. Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice. PLoS Pathogens, 2012; 8 (10): e1002995 DOI: 10.1371/journal.ppat.1002995
2) Grimaldi, D. and Engel, MS. Evolution of the insects. 2005. Cambridge University Press, NewYork, NY.
3) Cleveland, L.R., and A.V. Grimstone. The fine structure of the flagellate Mixotricha paraodoxa and its associated micro-organisms. 1964. Society 159:668-686.
4) Leadbetter, J.R. Acotgenesis from H2 Plus CO2 by Spirochetes from Termite Guts. 1999. Science 283:686-689.
5) Brugerolle G. Devescovinid features, a remarkable surface cytoskeleton, and epibiotic bacteria revisited in Mixotricha paradoxa, a parabasalid flagellate. Protoplasma. 2004 Oct;224(1-2):49-59.
6) Konig, H., Li Li, Wenzel, M, Frohlich, J.  Bacterial Ectosymbionts which Confer Motility. p. 86 Molecular Basis of Symbiosis. 2006. Springer-Verlag.
7) G A James, L Beaudette and J W Costerton. Interspecies bacterial interactions in biofilms. Journal of Industrial Microbiology & Biotechnology. Volume 15, Number 4 (1995), 257-262, DOI: 10.1007/BF01569978
8) Stanton TB, and Canale-Parola E. Treponema bryantii sp. nov., a rumen spirochete that interacts with cellulolytic bacteria. Arch Microbiol. 1980 Sep;127(2):145-56.
9) Tatiana Sitnikova,Ellinor Michel, Yulia Tulupova, Igor Khanaev, Valentina Parfenova, Larisa Prozorova. Spirochetes in gastropods from Lake Baikal and North American freshwaters: new multi-family, multi-habitat host records. Symbiosis. May 2012, Volume 56, Issue 3, pp 103-110.

Additional Reading:
Xinning Zhang and Jared R. Leadbetter. Evidence for Cascades of Perturbation and Adaptation in the Metabolic Genes of Higher Termite Gut Symbionts. mBio vol 3. no.4 e00223-12. http://mbio.asm.org/content/3/4/e00223-12.full
Nordhoff M, Wieler LH.Berl Munch Tierarztl Wochenschr. 2005 Jan-Feb;118(1-2):24-36 .[Incidence and significance of treponemes in animals].[Article in German]


Read More

Monday, February 27, 2012

0 Blog Log: Spirochetes Unwound On Persisters


Well, our favorite spirochete blogger has posted about the magic of antibiotic tolerance today - an apropos choice for this evening's post to follow on the heels of the discussion about Embers et al paper, "Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection".

While this entry on persisters in Spirochetes Unwound is not specifically about Borrelia, it is an interesting read for those who wish to learn more about the mechanisms related to antibiotic tolerance and how some bacteria can be dormant and survive its wrath.

Excerpt:
"Bactericidal antibiotics are effective at killing proliferating bacteria as long as they don't carry mutated or acquired genes that encode resistance to the antibiotics. Unfortunately even antibiotic-sensitive bacteria can tolerate antibiotics under some circumstances. Bacteria that are in a nondividing "dormant" state often survive antibiotic exposure. When the antibiotic is removed and growth resumes, the bacteria regain susceptibility to antibiotics.

At first glance antibiotic tolerance appears to be a passive process in which nondividing cells survive simply because the target of the antibiotic is inactive. However, this is not correct. Antibiotic tolerance requires an active response by the bacteria. The nondividing bacteria that survive antibiotic treatment are called persisters. Persisters may account for infections that are difficult to eradicate with antibiotics..."

Read more here: http://spirochetesunwound.blogspot.com/2012/02/magic-of-antibiotic-tolerance.html


Read More

Tuesday, February 21, 2012

0 More On Lyme Disease In Australia On The Today Tonight Show

There's been increased interest from my readers in learning more about Lyme disease in Australia, so I decided I would offer an update on the situation for everyone including my northern hemisphere readers who are interested in new developments there.

Last week, the Australian television news show, Today Tonight, posted a segment on Lyme disease in Australia and how it has become a controversial issue as a number of Australians who have never left the country were bitten by ticks and developed symptoms very much like those of Lyme disease.

As far as it is known, the bacteria which causes Lyme disease has not been detected in ticks in Australia - unless the researchers mentioned in the previous episode of Today Tonight which was covered here have finally discovered it.  Without their official announcement, though, it has been the situation that cases of Lyme disease within the country which have been confirmed were attributed to infections acquired overseas. Any recent reports of Lyme disease contracted within Australia have become controversial.

This week, Today Tonight has posted another segment about a man, Robert Sotur, who became ill on the job after numerous tick bites and won a government workmans compensation case due to an infection with Lyme disease.

This is pretty notable because he received compensation for a disease that the Federal Government, the Australian Medical Association, and Australian State Governments all say doesn't exist in Australia.

View the video of the show and transcript here: http://au.news.yahoo.com/today-tonight/health/article/-/12972227/lyme-disease-compensation/

A lawyer, David Jones (yes, seriously, David Jones - wonder how much tiresome joking he gets about that name), who is working on behalf of over fifty patients who never left Australia yet have come down with Lyme disease-like symptoms in Australia made this statement to Today Tonight:

"There needs to be an acceptance that there are many people within our community that are having symptoms that are Lyme or Lyme-like, and Governments need to take these people seriously. They need to commission the research, and they need to determine whether or not this disease, or a disease like it, exists here in Australia.”

He's right. If one man has won a workmans compensation case within Australia for falling ill after tick bites, there will likely be others. More than fifty, judging from his caseload alone. But there will be far fewer cases if the research is done to find the causative agent of this disease and to treat people for it as soon as possible.

If it is a bacterial agent, then unlike Ross River Virus and other viral infections which are more well known throughout Australia - early treatment can prevent more serious symptoms and potential permanent damage, and in the worst case scenario - death, as in the case of Karl McManus.

Given the limited amount of recent surveillance and examination of ticks for an indigenous spirochete that could cause a condition similar to Lyme disease - if not the potential importation of Borrelia spirochetes from neighboring Asia - it is not clear what reality is. The last major study to discover if Australian ticks harbored a spirochete similar to one that causes Lyme disease was conducted over 15 years ago. The situation may be different now.

Australian support groups for patients with tickborne illnesses have not only reported being bitten by ticks and falling ill afterwards - some have also reported infestations of bird mites preceding the onset of their symptoms. If this is the case, there may be more than one pathogen and more than one vector responsible for an overlapping set of symptoms in patients. Careful and thorough research is needed to sort it out.

My advice to any Australians reading this is whether or not the controversy of the existence of Lyme disease in your country is resolved soon that you do what you can to protect yourself from tick bites. Learn how to properly remove a tick to minimize the risk of infection, find a place to send your ticks for analysis, and educate yourself about the spectrum of symptoms which are related to ALL tickborne diseases and not just Lyme disease.

Tularemia was discovered in Tasmania last year and there is evidence beyond a doubt of its presence. Lyme disease now appears to be a possibility. And then there are those mosquito-borne and tickborne conditions of which many Australians are already familiar with such as Ross River Virus, Barmah Forest Virus, Tick Typhus, and Tick Paralysis - none of which you want if you can avoid them.

See a doctor if you suspect you have contracted a tickborne infection - remember, it may or may not be Lyme disease and treatment will be different for coinfections. But do go as soon as possible in order to prevent serious and potentially long-lasting complications.

And last but not least:

Petition your government, CSIRO, and local universities to do more research on tickborne illnesses including Lyme disease. Make sure you have your own homegrown research teams that will investigate the possibility of Lyme-like illnesses from pathogens transmitted by both bird mites and ticks. Ask Australian scientists to pave their own path and to not feel obliged to model all their investigations and guidelines for treatment based on those found in the northern hemisphere until it is more certain what is happening. In the meantime, treatment will probably be empiric and based on history, symptoms, and test results.

Here is a helpful link with short videos on the prevention of tick bites and safe removal of ticks:

Rather than just "Slip, Slap, Slop", learn to "Cover, Check, Clasp"?: http://campother.blogspot.com/2011/06/video-tick-removal.html

Fine-nosed tweezers are your friends, and not flame throwers and lighters...

Links to Australian tick bite related posts on this site:

About the first Today Tonight show this year on Lyme disease:
http://campother.blogspot.com/2012/02/lyme-disease-in-australia-on-today.html

On the outbreak of Tularemia in Tasmania late last year:
http://campother.blogspot.com/2011/11/tickborne-disease-outbreak-hits.html

On the use of marsupial cathelicidin peptides to fight infection:
http://campother.blogspot.com/2011/11/two-notable-antibiotic-articles-long.html

On Australian research on the relationship between tick bites and red meat allergies:
http://campother.blogspot.com/2011/04/tick-bite-you-stick-to-eating-fish-and.html

On Google search trends, and how Australians rank in the search for information on Lyme disease using Google:
http://campother.blogspot.com/2011/07/google-trends-on-lyme-disease.html

Links to Australian resources on Lyme disease outside of this blog:

CSIRO Public Health Advice on Ticks:
http://www.publish.csiro.au/?act=view_file&file_id=NB04047.pdf

The Karl McManus Foundation:
http://karlmcmanus.org/

Lyme Disease Association of Australia:
http://www.lymedisease.org.au/

Lyme Green Australia blog:
http://lymegreenaustralia.blogspot.com/



Read More

Friday, December 16, 2011

0 Science Article: Oral Bacteria Opens Door To Allow Pathogens In

In today's Science Daily, there is an article on a study showing how one specific oral bacteria, Fusobacterium nucleatum, can provide a gateway for other bacteria to enter human blood vessels and make people sick.

READ MORE Here: http://www.sciencedaily.com/releases/2011/12/111215113521.htm

Original Source:
Yann Fardini, Xiaowei Wang, Stéphanie Témoin, Stanley Nithianantham, David Lee, Menachem Shoham, Yiping W. Han. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Molecular Microbiology, 2011; 82 (6): 1468 DOI: 10.1111/j.1365-2958.2011.07905.x

Reading this reminded me of an earlier post and comments I made about a paper by Judith Miklossy: Alzheimer's disease - a neurospirochetosis.

In my comments there, I stated:

"I think it's possible that infection can be part of the precursor or a cascade effect that gets the ball rolling towards Alzheimer's Disease (AD) - but the question remains: Why do plenty of people have Bb or HSV-1 or any of a number of infections who do not develop AD?"

Maybe this is what makes the difference. Maybe Fusobacterium nucleatum has to cross the endothelium and open the gate for bacteria such as Bb or oral Treponema to cross the blood-brain barrier. If Fusobacterium nucleatum can travel to the brain first, then perhaps these other bacteria will follow on its heels and lead to neurological damage.

It seems further studies to seek Fusobacterium nucleatum in brain biopsies alongside other bacteria could provide some evidence that this is what has happened.

Read More

Tuesday, November 8, 2011

0 Two Notable Antibiotic Articles - Long-term Effects & Alternatives

H. pylori: Friend or foe?
Answer: It depends...
I know some of you reading along may have already seen this, but I think it bears mentioning again and also bears mentioning for those who may not have seen it: The New York Times recently published an article on the long-term effects of antibiotic usage, "In Some Cases, Even Bad Bacteria May Be Good".

After reading the above link, I found it fascinating and disturbing that antibiotics not only could contribute to obesity - the hypothesis originally being test driven by the writer - but that antibiotic use could also lead to allergies, inflammatory bowel disease, asthma, and gastroesophageal reflux. These are conditions which are not only common in Lyme disease patients, but in the general population as well.

Among the astonishing findings in this article:
  • Eradicating H. pylori infections entirely leads to the inability of ghrelin (a hunger hormone secreted in the stomach) to decrease in the stomach, thus leaving the brain to think it's always time to eat more. Therefore, lack of infection = eating more = weight gain.
  • Researchers found that the ratios of various bacteria in the guts of obese mice and obese humans were significantly different from those of lean controls, suggesting that altering the stomach’s microbial balance with antibiotics might put patients at risk for gaining weight. H. pylori is not the only culprit for change.
  • Less H. pylori in someone's system is associated with a greater risk of not only asthma but gastric reflux disease as well.
  • The human body contains a very complex bacterial ecosystem which we don't know anywhere near as much about as we should. Knowing about it is important in understanding the cause for disease and how to prevent it.
  • It's not just antibiotics that are changing the human microbiota - many aspects of modern life, including diet, smaller families, more hygienic practices and improved public sanitation, are affecting our bacterial communities.
The research cited contains sobering news and adds to the realization that as much as antibiotics have brought deadly infections under control and saved lives, they can have negative side effects and possibly more longer term consequences than at first realized.

All this said, I have been an advocate of antibiotic usage to treat Lyme disease - especially in its early stage and with a clear case of neuroborreliosis - because antibiotics have been tested and used in clinical trials for many years for their effectiveness. It's  important in the case of neuroborreliosis to ensure that treatment can pass the blood-brain barrier, and so far antibiotics have been tested which are demonstrated to have this property.

So I still stand by the use of antibiotics for their effectiveness and documented record for helping patients everywhere. However,  I am aware that in the future, antibiotics may not work as well as they once did due to antibiotic resistance, and this knowledge of longer term effects concerns me as well. Alternatives will need to be found that are safe and effective.

What sort of treatment could be available other than antimicrobial herbs?

The answer may be as close as your local wallaby.

Okay, well, for most people reading this, wallabies are hardly local to them - unless you are one of my Australian readers or you have a decent zoo nearby.

Last month, Byte Size Biology blog published an entry on the innate immune system and research on cathelicidins, specifically those peptides found within marsupials - including wallabies - which can fight off infection.

A baby kangaroo (joey) or wallaby is born in its fetal stage and must travel across its mother's abdomen and into a pouch to complete development. This can expose the fragile fetus to all sorts of germs, so what protects it? While the joey has adaptive immunity which is quite undeveloped, it can produce some killer all-purpose peptides he can use against microbes.

The same class of peptides are produced in Kanga’s milk. (Think of the idea as being similar to colostrum in cows, perhaps?) Collectively they are known as cathelicidins. Only about 30 amino acids long, these highly charged molecules kill both gram-positive and gram-negative bacteria.

Preliminary studies were conducted on the use of cathelicidins as antibiotics. The author of Byte Size Biology wrote:
"They used cathelicidins from wallaby and platypus to kill human pathogens: P. aeruginosa, K. pneumoniae and A. baumanii, including antibiotic resistant strains. Cathelicidins were much more effective than, well, antibiotics against those bacteria. Also, cathelicidins did not kill human red blood cells, which makes them a potential drug. Of course, immune reaction against cathelicidins as a foreign still needs to be checked, among many, many other things, but the whole idea of looking at marsupials is that, as mammals, they may be able to supply us with clues on how to synthesize a cathelicidin to be used as a drug in humans."
More research is needed, obviously, but this may be one option to antibiotics sitting in your medicine cabinet of the future.

Read More

Saturday, November 5, 2011

0 News: Tickborne Disease Outbreak Hits Australia

Brushtail possum
While there has been some controversy over the existence of Lyme disease in Australia, there is no debate over the existence of another tickborne illness, Tularemia - also known as rabbit fever caused by the bacteria, Francisella tularensis.

There are now two reported cases of Tularemia in residents from Tasmania, though the disease is more common in Asia and the US.

Reading about this news originally reminded me of a film I watched a few years ago, Rabbit Proof Fence - and it made me think that more surveillance than ever is needed for rabbits downunder... However, in this case, it was handling possums which gave the unlucky pair the infection. And even though ticks carrying Tularemia are often found on rabbits, the bacteria can affect 250 different species of mammals and birds.

The bacteria which causes the disease can live in wet environments for months and can be transmitted by contact, eating infected animals and through biting insects such as mosquitos, flies, and ticks.

Symptoms include fever, headaches, joint stiffness and shortness of breath. Complications include bone infection, infection of the sac around the heart(pericarditis), meningitis and pneumonia.

It is treatable with antibiotics but can be fatal if left untreated.

Read more:
http://www.news.com.au/breaking-news/rabbit-fever-health-alert/story-e6frfku0-1226185744925
http://www.themercury.com.au/article/2011/11/04/274135_tasmania-news.html

Video Announcement:


Read More

Wednesday, November 2, 2011

0 Science Articles: Probiotics As Anti-inflammatories, Bacterial Gene Transfer

Probiotics Effective in Combating Antibiotic-Associated Diarrhea, Studies Find; 'Good Bugs' Look Promising as Anti-Inflammatory Agents

In four different studies presented at the American College of Gastroenterology's (ACG) 76th Annual Scientific meeting in Washington, DC, researchers explored the effectiveness of probiotics for antibiotic-associated diarrhea; as an anti-inflammatory agent for patients with ulcerative colitis, psoriasis and chronic fatigue syndrome; and for people with abdominal discomfort and bloating who have not been diagnosed with a functional bowel disorder, such as irritable bowel syndrome (IBS).

Reference:
American College of Gastroenterology

READ MORE at source: http://www.sciencedaily.com/releases/2011/10/111031114951.htm

Bacteria May Readily Swap Beneficial Genes: Microbes Trade Genetic Coding for Antibiotic Resistance and More

Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).

Reference:
Chris S. Smillie, Mark B. Smith, Jonathan Friedman, Otto X. Cordero, Lawrence A. David, Eric J. Alm. Ecology drives a global network of gene exchange connecting the human microbiome. Nature, 2011; DOI: 10.1038/nature10571

READ MORE at source: http://www.sciencedaily.com/releases/2011/11/111101125958.htm

Read More

Monday, September 12, 2011

0 Science Articles Of Interest: C. difficile, Alzheimer's, and tinnitus

Since I haven't been doing a regular Friday Four column in some time, I haven't been posting about interesting articles as much lately. I wanted to take the time to point out a few which readers might take an interest in on combatting C. difficile, using antidepressants to fight Alzheimer's disease, and methods of stopping tinnitus in its tracks.

New way to treat common hospital-acquired infection: Novel approach may offer treatment for other bacterial diseases

 ScienceDaily (2011-08-22) -- Researchers have discovered a molecular process by which the body can defend against the effects of Clostridium difficile, an intestinal disease that impacts several million in the U.S. each year. A commonly acquired hospital infection, the disease has become more common, more severe and harder to cure mainly due to the emergence of a new, highly virulent strain of the bacteria that causes it.

Read More At This Link:
http://www.sciencedaily.com/releases/2011/08/110821141128.htm

References: Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins. Tor C Savidge, Petri Urvil, Numan Oezguen, Kausar Ali, Aproteem Choudhury, Vinay Acharya, Irina Pinchuk, Alfredo G Torres, Robert D English, John E Wiktorowicz, Michael Loeffelholz, Raj Kumar, Lianfa Shi, Weijia Nie, Werner Braun, Bo Herman, Alfred Hausladen, Hanping Feng, Jonathan S Stamler & Charalabos Pothoulakis. Nature Medicine 17, 1136–1141 (2011) http://www.nature.com/nm/journal/v17/n9/full/nm.2405.html

Comment: The good news about this research is that a drug known as protein s-nitrosylation inhibited Clostridium difficile toxins from destroying intestinal cells, and upcoming clinical trials on human subjects will test this drug treatment.

Antidepressants show signs of countering Alzheimer’s

Widely used antidepressants may reduce the ominous brain plaques associated with Alzheimer’s disease, a new study in mice and humans finds.

Brain scans of people who have taken antidepressants reveal fewer clumps of the protein amyloid-beta, a target of Alzheimer’s prevention strategies, when compared with people who have not taken the drugs.

Many in the field voiced caution about the results. But if borne out by further study, the findings may point to a new, relatively safe way to treat and prevent Alzheimer’s disease...

Read More At The Link: http://www.sciencenews.org/view/generic/id/333548/title/Antidepressants_show_signs_of_countering_Alzheimer%E2%80%99s

Comment: This makes me wonder how many different drugs we have in use for other purposes may be used to prevent Alzheimer's disease. If Alzheimer's disease is triggered by infection, would antibiotics plus antidepressants be a sensible treatment plan?

Tinnitus discovery could lead to new ways to stop the ringing

Neuroscientists at the University of California, Berkeley, are offering hope to the 10 percent of the population who suffer from tinnitus – a constant, often high-pitched ringing or buzzing in the ears that can be annoying and even maddening, and has no cure.

Their new findings, published online last week in the journal Proceedings of the National Academy of Sciences, suggest several new approaches to treatment, including retraining the brain, and new avenues for developing drugs to suppress the ringing.

"This work is the most clearheaded documentation to this point of what's actually happening in the brain's cortex in ways that account for the ongoing genesis of sound," said Michael Merzenich, professor emeritus of otolaryngology at UC San Francisco and inventor of the cochlear implant, who was not involved with the research. "As soon as I read the paper, I said, 'Of course!' It was immediately obvious that this is almost certainly the true way to think about it."

Read More At The Link: 
http://www.eurekalert.org/pub_releases/2011-09/uoc--tdc091211.php
Read More

Thursday, August 4, 2011

0 News: New bacterium found causing tick-borne illness ehrlichiosis in Wisconsin and Minnesota

 ScienceDaily (2011-08-03) -- A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota.

Experts say the new species from the Ehrlichia genus can cause a feverish illness in humans.

The new bacterium, not yet named, has been identified in more than 25 people and found in black-legged ticks, also known as deer ticks (Ixodes scapularis), in Minnesota and Wisconsin. Researchers used culture and genetic analyses.

Citing from the article, this is important to know:

"Doctors need to know to test for ehrlichiosis in the two states so the diagnosis is not missed. However, traditional blood antibody tests may offer misleading results and fail to accurately identify the new species. A specific antibody test for the new bacterium has been developed by the CDC but isn't widely available. Instead, a molecular blood test that detects DNA from the new Ehrlichia species is the preferred method for detecting this disease in symptomatic patients."

READ MORE: http://www.sciencedaily.com/releases/2011/08/110803174745.htm#

Read More

Friday, April 29, 2011

1 The Friday Four

In this week's Friday Four, we'll look at how some bacteria avoid antibiotics by shutting down and hiding until it's safe to come out again,  students who go bacteriophage hunting,  disrupting bacteria's communication or quorum sensing in future antibacterial treatments,  tests which use bacteria's scent to detect not only their presence but species, strain, and their antibiotic resistance profile.

CO message to readers: The Friday Four postings will be on hiatus for at least the month of May during Lyme Awareness Month.

1) 'Going off the grid' helps some bacteria hide from antibiotics

Link: http://www.sciencedaily.com/releases/2011/04/110425153611.htm

ScienceDaily (2011-04-25) -- Call them the Jason Bournes of the bacteria world. Going "off the grid," like rogue secret agents, some bacteria avoid antibiotic treatments by essentially shutting down and hiding until it's safe to come out again.

Comments:

I want to keep this one short and sweet: What if those few Borrelia burgdorferi left behind in collagen that some researchers say are not viable or non-dividing are just basically in stasis instead? What if they have shut down their metabolic processes and only look mostly dead? (This is starting to remind me of the scene in that movie, The Princess Bride, where Westley is... Oh, never mind, if you haven't seen it, I don't want to spoiler it for you. It's a fun movie. I will tell you the Bourne series is one of the best action series in my opinion - along those lines, I like Memento too...)

Source Reference:
Xiaoxue Wang, Younghoon Kim, Seok Hoon Hong, Qun Ma, Breann L Brown, Mingming Pu, Aaron M Tarone, Michael J Benedik, Wolfgang Peti, Rebecca Page, Thomas K Wood. Antitoxin MqsA helps mediate the bacterial general stress response. Nature Chemical Biology, 2011; DOI: 10.1038/nchembio.560

2) Phage hunting students find new bacteriophages in soils of St. Louis suburbs

Link: http://www.sciencedaily.com/releases/2011/04/110425135645.htm

ScienceDaily (2011-04-25) -- Twelve students who had participated in an unusual biology course as freshmen have found two bacteriophages, viruses that prey exclusively on bacteria, in the soil of two suburbs of St. Louis, Missouri. As the finders, they had the naming rights; the new phages are called Angelica and Uncle Howie.

Comments:

This is as awesome as being an amateur astronomer. If you're an amateur astronomer, if you find an object in the sky no one has discovered before, it can be named after you or you can decide what you want to name it. Here, students are discovering their own bacteriophages in the dirt and naming them anything they want.

I posted this mainly because I think it's cool, and I wish I had gotten the opportunity to do this in school, too. Well, who knows... maybe I'll go back to school someday, just to be able to take a course like this and name my own bacteriophage Camp Other. If I did, though, I'd try to find one that consumed Borrelia burgdorferi.

Source Reference:
Pope WH, Jacobs-Sera D, Russell DA, Peebles CL, Al-Atrache Z, et al. Expanding the Diversity of Mycobacteriophages: Insights into Genome Architecture and Evolution. PLoS ONE, 2011; 6 (1): e16329 DOI: 10.1371/journal.pone.0016329

3) Bacteria interrupted: Disabling coordinated behavior and virulence gene expression

Link: http://www.sciencedaily.com/releases/2011/04/110421122329.htm

ScienceDaily (2011-04-22) -- New research reveals a strategy for disrupting the ability of bacteria to communicate and coordinate the expression of virulence factors. The study may lead to the development of new antibacterial therapeutics.

Comments:

Bonnie Bassler is up to it again. I love her presentation on TED, and if you haven't seen it, you really should set aside 18 minutes of your time to watch her video on how to get bacteria to talk and how to get them to shut up.

And recently she was on a team that did more research on how to stop bacterial infections by shutting up them up.  Four points in turn outlined their strategy for how one could stop bacterial infection by stopping quorum sensing:

  1. Quorum-sensing (QS) antagonists represent potential antibacterial therapeutics
  2. They can bind LuxR-family transcription factors in competition with autoinducers
  3. The antagonists stabilize a closed conformation incapable of binding operator DNA
  4. This inhibition strategy may be generalizable to other multidomain receptors

Which means that there are antagonists which can bind to certain factors that normally autoinducers would bind to - the antagonists are competition for them,  much like Saccharomyces bouldarii can be competition for other yeasts and C. difficle. When the antagonists bind to the factors, they will not bind to operator DNA.

So to sum up: If you can stop autoinducers, you can stop the bacteria from communicating. You can shut it up. If you shut it up, you can tell it to stop having sex and the immune system police will evict it, much like a loud annoying neighbor.

You think I'm kidding, and making this story up? I'm not - I'm merely telling the story to illustrate a point: In order for gene transcription to be activated in the bacteria, the cell must encounter autoinducers secreted by other cells in its environment.

Here's a basic diagram of how Gram-negative bacteria engages in quorum sensing (noting that Borrelia burgdorferi is not exactly Gram-negative or Gram-positive here, it is somewhat closer to Gram-negative so I include that model here):



What you need to imagine here is that this oval represents a bacterium, and that initially a small number of bacteria are doing this all at the same time in their host, whether that be human or not.

Here the LuxI protein makes the autoinducers (green pentagons) which then diffuse freely outside. Each bacterium doing the same, the concentration of external autoinducer is a measure of the size of the population (quorum).

When the autoinducer concentration is high (meaning the bacteria has reproduced to a certain population)  the autoinducer binds to a cognate receptor LuxR (cognate means having the same form and ad hoc characteristics to bind specifically to the molecule it receives).

This is quorum sensing.

The complex auto inducer-Lux R then binds at target gene promoters and activate their effect (transcription) which has behavioral consequences.

In other words, once the bacteria reaches a certain threshold, the level of autoinducers is very high, and the number of bacteria goes up. The high autoinducer level means more bacteria, and more bacteria means more autoinducers. It's a self-perpetuating feedback loop. If you can prevent the loop from even getting started, bacterial numbers will remain low.

So, you're probably wondering, does Borrelia burgdorferi engage in quorum sensing, and if so, can we get it to shut up also?

This has actually been somewhat under debate. Some research has stated that Borrelia burgdorferi has an autoinducing cognate receptor called LuxS, but it doesn't have the necessary autoinducer to bind to it, which in this case would be AI-2.

More recent research has shown that there might be a more complicated method for Borrelia burgdorferi involved for synthesizing its own autoinducers... Might.

To draw from this Polish research paper from 2009 (http://www.aaem.pl/pdf/16001.pdf):

"...the studies of von Lackum et al.[62] demonstrated that B. burgdorferi encodes functional Pfs and LuxS enzymes for the breakdown of toxic products of methylation reactions. According to these observations, B. burgdorferi was shown to synthesize the final product, 4,5-dihydroxy-2,3-pentanedione (DPD) during laboratory cultivation. DPD undergoes spontaneous rearrangements to produce a class of pheromones collectively named autoinducer 2 (AI-2). The addition of in vitro-synthesized DPD to the culture of B. burgdorferi manifested in differential expression of a distinct subset of proteins, including the outer surface lipoprotein VlsE. Although many bacteria for regeneration of methionine can utilize the other LuxS product, homocysteine, B. burgdorferi did not show such an ability. It is hypothesized that B. burgdorferi produces LuxS for the express purpose of synthesizing DPD, and utilizes a form of that molecule as an AI-2 pheromone to control gene expression [4]."

Those cited papers are:

[62] Von Lackum K, Babb K, Riley SP, Wattier RL, Bykowski T, Stevenson B: Functionality of Borrelia burgdorferi LuxS: the Lyme disease spirochete produces and responds to the pheromone autoinducer-2 and lacks a complete activated-methyl cycle. Int J Med Microbiol 2006, 296, 92-102 -and-
[4] Babb K, von Lackum K, Wattier RL, Riley SP, Stevenson B: Synthesis of autoinducer 2 by the lyme disease spirochete, Borrelia burgdorferi. J Bacteriol 2005, 187, 3079-3087

I need to read more about it, at this point the above is currently hypothetical and an in vitro test, so the answer to your question is (unless you know something I don't): the jury is still out on this one.
.
Source Reference:
Guozhou Chen, Lee R. Swem, Danielle L. Swem, Devin L. Stauff, Colleen T. O'Loughlin, Philip D. Jeffrey, Bonnie L. Bassler, Frederick M. Hughson. A Strategy for Antagonizing Quorum Sensing. Molecular Cell, Volume 42, Issue 2, 199-209, 22 April 2011 DOI: 10.1016/j.molcel.2011.04.003

4) Get a whiff of this: Low-cost sensor can diagnose bacterial infections

Link: http://www.sciencedaily.com/releases/2011/04/110427171636.htm

Colorimetric sensor array
overlaid on petri dish
ScienceDaily (2011-04-28) -- Bacterial infections really stink. And that could be the key to a fast diagnosis. Researchers have demonstrated a quick, simple method to identify infectious bacteria by smell using a low-cost array of printed pigments as a chemical sensor. In only a few hours, the array not only confirms the presence of bacteria, but identifies a specific species and strain. It even can recognize antibiotic resistance -- a key factor in treatment decisions.

Comments: So the abstract for this paper is as follows:
"Rapid identification of both species and even specific strains of human pathogenic bacteria grown on standard agar has been achieved from the volatiles they produce using a disposable colorimetric sensor array in a Petri dish imaged with an inexpensive scanner. All 10 strains of bacteria tested, including Enterococcus faecalis and Staphylococcus aureus and their antibiotic-resistant forms, were identified with 98.8% accuracy within 10 h, a clinically important time frame. Furthermore, the colorimetric sensor arrays also proved useful as a simple research tool for the study of bacterial metabolism and as an easy method for the optimization of bacterial production of fine chemicals or other fermentation processes."
The full text requires paid access, however, just looking at what is known here between the article and abstract, I have to wonder how accurate a test this could be to detect Borrelia burgdorferi. I could see this rapid strain identification being useful for identifying bacteria for bacteriophage treatments and also for detecting the presence of bacteria on specific surfaces in hospitals or from open wounds. This wouldn't work well for something that is deeply embedded in collagen, but it might work from a synovial fluid sample better than current detection tests for Bb there.

Source Reference:
James R. Carey, Kenneth S. Suslick, Keren I. Hulkower, James A. Imlay, Karin R. C. Imlay, Crystal K. Ingison, Jennifer B. Ponder, Avijit Sen, Aaron E. Wittrig. Rapid Identification of Bacteria with a Disposable Colorimetric Sensing Array.Journal of the American Chemical Society, 2011; : 110427110353066 DOI: 10.1021/ja201634d
Read More

Friday, April 15, 2011

0 The Friday Four

In this edition of the Friday Four, we'll look at the impact of antibiotics on bacteria in dogs' intestines, how fire-bellied toads can help us fight germs, antibiotic cocktails in wasp cocoons, and the effect of stress on your gut flora.

1) Impact of antibiotic treatments on bacteria in the intestines of animals

Source Link: http://www.sciencedaily.com/releases/2010/04/100413081238.htm

ScienceDaily (2010-04-13) -- Recent research from Norway has found that resistance to antibiotics is on the increase in intestinal bacteria in animals as a direct result of antibiotic treatments. The antibiotics also alter the composition of bacteria in the intestines. These discoveries provide more knowledge about the undesirable effect of antibiotic treatments and are of comparative interest as regards other animals and humans.

Comments:

This article is about how within a few days of antibiotic treatment, healthy dogs had a lot of antibiotic resistant E. coli bacteria in their intestines. I shudder to think of the state of my own intestines, after many months of antibiotic use.

I don't know if I really have much to say here, other than to say this: The article quoted nearly 50% of all worldwide antibiotic use is veterinary - I wonder what percentage of that 50% is for factory farms and not for people's pets? Antibiotics should be conserved for pets and people on the rare occasion they need them, and this should have been done all along. 

Now we're facing a crisis situation with antibiotic resistance, one which is most readily observed in our hospitals. And not just our hospitals, but our kitchens...

This was the eye-opener today:

Nationwide study finds US meat and poultry is widely contaminated

Multi-drug-resistant Staph found in nearly 1 in 4 samples, review shows


FLAGSTAFF, Ariz. — April 15, 2011 — Drug-resistant strains of Staphylococcus aureus, a bacteria linked to a wide range of human diseases, are present in meat and poultry from U.S. grocery stores at unexpectedly high rates, according to a nationwide study by the Translational Genomics Research Institute (TGen).

Nearly half of the meat and poultry samples — 47 percent — were contaminated with S. aureus, and more than half of those bacteria — 52 percent — were resistant to at least three classes of antibiotics, according to the study published today in the journal Clinical Infectious Diseases.


Please COOK YOUR FOOD THOROUGHLY.

Other methods of fighting bacterial infections which do not promote resistance must be found.

Which leads us to the next two entries of this Friday Four...


2) Giant fire-bellied toad's brain brims with powerful germ-fighters

Source link: http://www.sciencedaily.com/releases/2011/04/110413121010.htm

ScienceDaily (2011-04-13) -- Frog and toad skins already are renowned as cornucopias of hundreds of germ-fighting substances. Now a new report reveals that the toad brains also may contain an abundance of antibacterial and antiviral substances that could inspire a new generation of medicines.

Comments:

So the "germ-fighting substances" they're talking about are peptides. Many of these peptides were shown to be homologous to hormones and neurotransmitters of mammals. And in recent years it has been shown that these secretions also contain a multitude of antimicrobial peptides.

So in the original research report above, 79 antimicrobial peptides were found to be encoded by 158 cDNA clones from B. maxima (the giant fire bellied toad - see photo to left) and B. microdeladigitora brain cDNA libraries, and of those 79, 20 were the same as ones which had been found before - but 59 were previously unknown and new antimicrobial peptides. These peptides worked against Gram-positive and Gram-negative bacteria and fungi.

Earlier research on these other amphibian-derived peptides have shown that some have activity against mycoplasma infections, HIV, and Staphlococcus aureus.

Antibiotics have been derived from peptides for many years now - some synthetically, like polymyxins and bacitracins - and some are natural, nonsynthetic antibiotics, like melittin (which peptides had to be derived from - melittin itself was not used due to its hemolytic properties) and manuka honey itself.

The latter group rely on observing natural host defenses (as nature’s antibiotics) and the clinical potential of peptides derived from these natural sources - amphibians, insects, mammals, and plants - is something that continues to be studied. These natural antibiotics may replace more of our currently existing selection of antibiotics due to increasing resistance.

Source Reference:
Rui Liu, Huan Liu, Yufang Ma, Jing Wu, Hailong Yang, Huahu Ye, Ren Lai. There are Abundant Antimicrobial Peptides in Brains of Two Kinds ofBombinaToads.Journal of Proteome Research, 2011; 10 (4): 1806 DOI:10.1021/pr101285n

3) Bacteria in wasp antennae produce antibiotic cocktails

Source link: http://www.sciencedaily.com/releases/2011/04/110411194823.htm

ScienceDaily (2011-04-12) -- Bacteria that grow in the antennae of wasps help ward off fungal threats by secreting a 'cocktail' of antibiotics, according to researchers.

Comments:

Who knew that a particular wasp - the beewolf wasp (weird name?) - could have something in common with Lyme disease patients?

These crafty little buggers have their own prophylactic antibiotics right on the outside of their cocoons, so that they are protected from disease when they are transforming from larvae into wasps.

Female beewolf digger wasps cultivate symbiotic Streptomyces bacteria in unique antennal glands and secrete them into their larval brood cells. Then the larvae take up the bacteria and weave them into the cocoon while spinning it. The result is a cocoon which produces at least 9 different antibiotic and antifungal substances.

The article makes a statement that reflects the fact that a number of LLMDs have been ahead of the curve when it comes to treating infections. It states:

"A similar combination prophylaxis (also known as combination therapy) approach is increasingly used in human medicine. Such a treatment exploits the complementary action of two or more antibiotics. It results in a higher efficacy against a broader spectrum of pathogens and is known to prevent micro-organisms from developing resistance to the antibiotic substance."

There is a logic behind combination antibiotic treatment - testing and documenting the efficacy of such combinations goes a long way to supporting long-term antibiotic use where it is needed, especially if lack of resistance can be shown.

The beewolf larva hibernates for several months in its cocoon before the 
adult insect hatches. Antibiotics on the surface of the cocoon, produced by symbionts, guarantee protection against microbial pests during such a protracted developmental stage. The amount of antibiotics was visualized by means of imaging techniques based on mass spectrometry 
(LDI imaging) and merged as pseudocolors onto the cocoon.
Credit: Johannes Kroiss and Martin Kaltenpoth, MPI for Chemical Ecology, Jena (Photomontage).

Source reference:
http://www.sgm.ac.uk/default.cfm

4) Don't Stress - It messes with your gut flora

Source Link: http://researchnews.osu.edu/archive/immunegut.htm

Research out of Ohio State University informs us more about the value of the mind-body connection in affecting our health.

Stress not only sends the human immune system into overdrive - it can also wreak havoc on the trillions of bacteria that work and thrive inside our digestive system. New research suggests that this may be important because those bacteria play a significant role in triggering the innate immune system to stay slightly active, and thereby prepared to quickly spring into action in the face of an infection.

So this is what the study was about:
For two hours daily for six days, an aggressive mouse was placed in a cage of a group of more docile, laid-back mice.

At the end of the string of experiments, blood samples were taken from both stressed animals and matched mice from a control group, along with samples of material from inside each animal’s intestine. The blood samples were analyzed to detect the levels of two biomarkers used to gauge stress – a cytokine called interleukin-6 (IL-6) and a protein called MCP-1 that summons macrophages, or scavenger cells, to the site of an infection.

From the intestinal samples, Bailey’s team could determine the relative proportion of at least 30 types of bacteria residing there.

“We know now that if we knock the population of bacteria down with antibiotics, we don’t have the same innate immune response,” Bailey said. “That showed that the bacteria are involved in the ability of stress to prime the innate immune system.”

Compared to the control mice, the stressed animals showed two marked differences: The proportion of one important type of bacteria in the gut – Bacteroidesfell by 20 to 25 percent while another type – Clostridiumincreased a similar amount. Also, levels of the two biomarkers, IL-6 and MCP-1, jumped 10-fold in the stressed mice, compared to controls.

The researchers then treated stressed mice with broad-spectrum antibiotics that could kill as much as 90 percent of the intestinal bacteria for a short period. When they again looked at the two immune biomarkers in the stressed mice, they saw only a doubling of IL-6 and MCP-1 – an increase only one-fifth as much.
Comments:

Stress really affects the immune system - who knew? It's well-known it does, but what isn't known is exactly how it does this - and what can be done other than to get people out of your life who act like aggressive mice.

There is evidence here that stress increases the population of unfriendly and harmful bacteria, and later on, the use of antibiotics knocks down the bacteria needed to prime the immune system.

Healthy stress management and joy are needed in one's life, even while fighting off illness. Especially while fighting off illness.
Read More

Friday, April 8, 2011

14 The Friday Four

In this week's edition of the Friday Four, we look at the IDSA's plan to combat antibiotic resistance with a brief recap of highlights of the STAAR Act, using artemisinin and hyperbaric oxygen as a potential cancer treatment, a dangerous new tickborne virus identified in China, and creating a new antibiotic using marine bacteria.

1) Lifesaving antibiotics face doubtful future

Source link: http://www.sciencedaily.com/releases/2011/04/110407121435.htm

ScienceDaily (2011-04-07) -- To head off a health care disaster, the Infectious Diseases Society of America has developed a plan to combat deadly antibiotic-resistant "super bugs" and is rolling out the multi-pronged plan today, on World Health Day 2011.

Comments: I don't know why this is considered the latest news on ScienceDaily... this plan is basically a repeat of all that is found in the STAAR Act.

I wrote about the IDSA's 2010 testimony to the House Committee back in early January. I posted about it on Lymenet, too.

Did anyone notice back then? I sure hope people notice now.

I'll repeat here what I wrote back in January:
This act should be more familiar to you all, because the STAAR Act stands for "Strategies to Address Antimicrobial Resistance".


Taken from the final 2010 report from the IDSA to the House Committee on Energy and Commerce Subcommittee on Health:


"The STAAR Act strengthens existing efforts by establishing an Antimicrobial Resistance Office (ARO) within the HHS Office of the Assistant Secretary of Health. The Director of ARO will serve as the director of the existing interagency task force. The Act also establishes a Public Health Antimicrobial Advisory Board (PHAAB) comprised of infectious diseases and public health experts who will provide much-needed advice to the ARO Director and task force about antimicrobial resistance and strategies to address it. The STAAR Act will strengthen existing surveillance, data collection, and research activities as a means to reduce the inappropriate use of antimicrobials, develop and test new interventions to limit the spread of resistant organisms, and create new tools to detect, prevent and treat drug-resistant “bad bugs.”" 
And that's just part of it, really - you ought to read the entire report.

One of the IDSA's broader goals beyond this act is to institute a special fee called "the Antibiotic Innovation and Conservation Fee" on every course of antibiotics used by doctors and veterinarians in the future - both to acquire money for funding new antibiotic development - and to encourage restricted and judicial use of the antibiotics remaining in use. And then there is also the proposal for an "antibiotic stewardship program" which will be intended to track and reduce usage of antibiotics as well as lower medical cost.

This is one of the reasons I mention the issue of needing more research into the issue of persistence, and that it can't wait. It already couldn't wait, but now it becomes a more important issue. If persistence is proven, then long-term use of antibiotics to treat Lyme disease beyond the standard minimum would be accommodated - but if it isn't, then with the passage of the STAAR Act, if the proposed antibiotic stewardship program passes along with it - could affect Lyme disease patients on long-term antibiotics a lot.

How far will this act go, and how does one determine what the "inappropriate use of antimicrobials" actually is?

I'm in support of stopping antibiotic use on healthy livestock and think antibiotic use can be cut back for ear infections and acne. I'm in support of hospitals practicing more safe hygiene controls and using UV irradiated keyboards - if not UV-C doused rooms between patients - to reduce the spread of potentially deadly MRSA and C. difficile. I see the value of the STAAR Act  - especially in reducing the spread of resistant organisms and funding new antibiotics - the world desperately needs new antibiotics, including Lyme disease patients. Even better, I'd like to see development of technology that stops infection in its tracks without the use of antibiotics - thus avoiding the concern over resistance entirely. In the meantime, though? I have concerns this act could potentially be a strike against Lyme disease patients in getting ongoing treatment. It all depends on the implementation.

2) Kill Cancer Naturally - With Hyperbaric Oxygen and Artemisia Annua L. aka Artemisinin

Artemisia Annua or
"Sweet Annie"

ScienceDaily (Apr. 4, 2011) — An environment of pure oxygen at three-and-a-half times normal air pressure adds significantly to the effectiveness of a natural compound already shown to kill cancerous cells, researchers at the University of Washington and Washington State University recently reported in the journal Anticancer Research.




Link: http://www.sciencedaily.com/releases/2011/04/110404142813.htm

Comments:  And you thought Artemisinin was just for Babesia and Malaria treatment... In the future it might be used to treat cancer - only time will tell.

Seriously, someone needs to do more research using hyperbaric oxygen chambers. This could be something useful - and it should be easy enough to test on human volunteers under the supervision of a medical professional.

Note, though, that this study wasn't on actual people with cancer - it is a study in which the researchers used artemisinin or high-pressure oxygen alone on a culture of human leukemia cells. Results on cancer cells in vivo in people who sit in hyperbaric oxygen chambers may differ - this is something that needs to be tested in the future.

They found out that using either the artemisinin or the oxygen reduced the cancer cells' growth by 15 percent. But if they used them in combination - over a 48 hour period after 90 minutes of high-pressure oxygen - the cancer cells' growth was reduced by 38 percent. That's an over 50 percent increase in artemisinin's effectiveness.

Henry Lai, UW research professor of bioengineering, said that, "Artemisinin is a promising low-cost cancer treatment because it's specific, it's cheap and you don't have to inject it. It's 100 times more specific than traditional chemotherapy. In breast cancer, it's even better."

Is that true? A 100 times more specific? How? Where is he getting this information from? I want to know.

At any rate, it would be interesting to hear more about this and see further studies.

[ Side note: Science Daily's write up mentions that the FDA has approved the use of hyperbaric oxygen therapy chambers for Lyme disease - when that is not true. HBOT has only been approved for the use of 13 indications, and Lyme disease is not one of them - treatment with HBOT for Lyme disease is considered an off-label use or experimental. ]

Publication source:
Yusuke Ohgami, Catherine A. Elstad, Eunhee Chung, Donald Y. Shirachi, Raymond M. Quock, Henry C. Lai.Effect of Hyperbaric Oxygen on the Anticancer Effect of Artemisinin on Molt-4 Human Leukemia Cells.Anticancer Research, 2010; 30: 4467-4470 [link]

3) New Tickborne Virus In China Has High Mortality Rate

Source link: http://www.scienceagogo.com/news/20110222214117data_trunc_sys.shtml

Writing in the New England Journal of Medicine, scientists explain how a previously unknown and dangerous virus carried by ticks has been responsible for seasonal outbreaks of the disease in six of China's most populated provinces.

The newly discovered pathogen has been dubbed 'Severe Fever with Thrombocytopenia Syndrome virus'. It has been placed in the Bunyaviridae family, along with the hantaviruses and Rift Valley Fever virus.

Symptoms include high fever and gastrointestinal disorder; the mortality rate was initially estimated at 30 percent.

Comments:  This is scary. I think between the TBE in Europe and this, my next vacation will be at McMurdo station.

4) New Drugs From Bugs

Source Link: http://www.sciguru.com/newsitem/7751/New-drugs-from-bugs/

bioluminescent marine
bacteria on agar
This is interesting news from the UK... Chemists from Bristol and microbial geneticists from Birmingham determined the sequence of the complete DNA content of a marine bacterium that produces the new antibiotic, thiomarinol (owned by Daiichi-Sankyo). They then identified the genes responsible for making the antibiotic on the basis of their similarity to genes that make the related but less potent antibiotic, mupirocin, which is currently used to combat MRSA (methicillin resistant Staphylococcus aureus).

They found the genes are on a relatively small, separate DNA molecule called a plasmid, which is just big enough to carry the genes for making the antibiotic plus genes to allow the plasmid to replicate autonomously in the bacterium. The plasmid thus carries genes that make both the mupirocin-like antibiotic as well a second antibiotic, holomycin, and a gene responsible for joining both antibiotics together, forming a more potent molecule.

Tests showed that by joining the antibiotics together the resulting chemical is able to inhibit the growth of MRSA strains that have become resistant to mupirocin.

Comments: Read more at the link. I think it's pretty interesting to learn about how new antibiotics are made, even though I would like to find a way to fight infection using other medications and other technologies. We really need antibiotics that don't eventually become resistant and don't cause C. difficile infections (or imbalances that lead to infections, in a number of cases) - or we need an entirely different infection-fighting approach. This development of new antibiotics in the meantime is something desperately needed worldwide, and I'm glad to see it happening - I just wonder how long it will take before clinical trials are on the horizon...

Related Publications:
A natural plasmid uniquely encodes two biosynthetic pathways creating a potent antibiotic.
D. Fukuda, A. S. Haines, Z. Song, A. Murphy, J. Hothersall, E. R. Stephens, R. Gurney, C.
Riemer, R. Marshall, R. J. Cox, J. Crosby, C. L. Willis, T. J. Simpson and C. M. Thomas,
PLoS ONE, 2011, 6, in press.

Nature Reviews Microbiology 8, 281-289 (April 2010) | doi:10.1038/nrmicro2278
Resistance to and synthesis of the antibiotic mupirocin
Christopher M. Thomas, Joanne Hothersall, Christine L. Willis, Thomas J. Simpson
http://www.nature.com/nrmicro/journal/v8/n4/full/nrmicro2278.html
Read More

The Camp Other Song Of The Month


Why is this posted? Just for fun!

Get this widget

Lyme Disease

Borrelia

Bacteria

Microbiology